{"SPADE_UN_17034": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17034", "Peptide Name": "[Glu(Me)]cyO2", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "GIPCGXSCVWIPCISSAIGCSCKSKVCYRN", "Sequence Length": 30, "UniProt Entry": ["http://www.uniprot.org/uniprot/P58434"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:U-937/GTB (IC50=36(32-40)μM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C128H206N36O36S6", "Mass": 364508, "PI": 8.38, "Net Charge": 3, "Hydrophobicity": 0.56, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Key role of glutamic acid for the cytotoxic activity of the cyclotide cycloviolacin O2", "Pubmed ID": "16389447", "Reference": "Cell Mol Life Sci. 2006 Jan;63(2)235-45.", "Author": "Herrmann A, Svangård E, Claeson P, Gullbo J, Bohlin L, Göransson U.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16389447"}], "Frequent Amino Acids": "CSI", "Absent Amino Acids": "DEFHLMOQTU", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 11, "Polar Residues": 19, "Positive Residues": 3, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_00750", "Similarity": 1.0, "Sequence": "GIPCGESCVWIPCISSAIGCSCKSKVCYRN"}, {"SPADE_ID": "SPADE_N_06877", "Similarity": 1.0, "Sequence": "CGESCVWIPCISSAIGCSCKSKVCYRNGIP"}, {"SPADE_ID": "SPADE_N_00350", "Similarity": 0.9655172413793104, "Sequence": "GIPCGESCVWIPCITSAIGCSCKSKVCYRN"}]}}}